Sponsor hub

University of Wisconsin, Madison clinical trial failures

Review 75 stopped clinical trials from University of Wisconsin, Madison, including disease areas, phases, and classified stop reasons.

This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.

Total stopped trials75
Likely biological signals3
Shown below75

Dominant stop reasons

OPERATIONAL
47
OTHER/UNKNOWN
25
EFFICACY/FUTILITY
2
SAFETY
1

Notable sponsors

University of Wisconsin, Madison
75

Related phases

Phase II
32
Phase I
24
Phase IV
10
Unknown
7
Early Phase I
2

Crawlable stopped-trial records

Open Explore

Showing up to 75 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.

NCT02833207: Peripheral Vasodilation in Obese Humans

Phase I Obesity trial by University of Wisconsin, Madison. Stop reason: OPERATIONAL.

Due to COVID-19, difficulty obtaining study drugs, difficulty recruiting obese subjects, and limited access to on-call physicians.